Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00109174 · ClinicalTrials.gov registry record · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
A NA study of Normal Physiology, sponsored by National Institute of Mental Health (NIMH).
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00109174: Recruiting NA study of Normal Physiology, sponsored by National Institute of Mental Health (NIMH).
NCT00109174 is a NA study of Normal Physiology that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 200 participants, below the 1,285-participant average among 25 other Normal Physiology trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00109174, a NA study of Normal Physiology, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use magnetic resonance spectroscopy (MRS) to measure in the brain the transfer of \[13\]C as it is naturally metabolized from glucose to specific chemical transmitters. From this method, we can measure the rate of production of an important excitatory neurotransmitter (glutamate) as well as an inhibitory neurotransmitter (GABA).
Primary Outcome
To obtain more accurate and reliable MRS data from the human brain
Conditions Studied
Interventions
- DEVICE 3T and 7T device
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-09-06 |
| Est. Completion | 2030-03-11 |
| Phase | NA |
What NCT00109174 shows while recruiting
NCT00109174 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 25 other Normal Physiology trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Normal Physiology appearing as the primary indexed condition, and to 1 intervention - of which 3T and 7T device is the first listed.
NCT00109174 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00109174 about?
NCT00109174 is a clinical study titled "MRS Measurement of Glutamate and GABA Metabolism in Brain". This study will use magnetic resonance spectroscopy (MRS) to measure in the brain the transfer of \[13\]C as it is naturally metabolized from glucose to specific chemical transmitters. From this method, we can measure the rate of production of an important excitatory neurotransmitter (glutamate) as ...
What is the current status of trial NCT00109174?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2006-09-06. Estimated completion is 2030-03-11.
What conditions does trial NCT00109174 study?
This clinical trial studies the following conditions: Normal Physiology.
What interventions are being tested in trial NCT00109174?
The interventions under investigation include: 3T and 7T device (DEVICE).
Who is sponsoring clinical trial NCT00109174?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00109174 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Normal Physiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00109174's enrollment target sits among peer trials
200 13th of 25 higher than 12 of 25 other Normal Physiology trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Normal Physiology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
RECRUITING · NA
-
Sociocultural & Biobehavioral Influences on Pain Expression and Assessment
RECRUITING · NA
-
Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array
RECRUITING · NA
-
Defining Neurobiological Links Between Substance Use and Mental Illness
RECRUITING · NA
-
Impact of Sex and Age on Non-visual Light Input That Affects Sleep and Circadian Rhythms
RECRUITING · NA
-
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
- NCT00568490 · 200 participants
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI